Skip to main content
SpringerLink
Log in

Albumin-human/tolvaptan

Lack of efficacy: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tsuruya K, et al. First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan. BMJ Open Gastroenterology 10: no pagination, No. 1, Jan 2023. Available from: URL: http://doi.org/10.1136/bmjgast-2023-001120

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Albumin-human/tolvaptan. Reactions Weekly 1961, 21 (2023). https://doi.org/10.1007/s40278-023-41278-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-41278-8

Search

Navigation